Clinical Trials · NCT02560376
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- Phase
- EARLY_Phase 1
- Recruitment status
- Unknown
- Sponsor
- Peking Union Medical College Hospital
- Enrollment
- 100
- Start date
- Feb 2014
- Locations
- 1 site, China
- Primary endpoint
- Standardized uptake value of 68Ga-NOTA-exendin-4 PET/CT in Diagnosis of Insulinoma and Nesidioblastosis